Our group has previously shown that Mcl-1 is overexpressed in oral cancer and is closely associated with poor clinical outcomes, suggesting that the inhibition of Mcl-1 might be a good strategy for the treatment of oral cancer [25, 26]. Here, MCL1 is linked to lip and oral cavity carcinoma.